Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Tremblay

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Combinatorial Chemistry|July 13, 2004
Steroids and combinatorial chemistryRené Maltais, Martin R Tremblay, Liviu C Ciobanu, et al.
Expert Opinion on Therapeutic Patents|June 10, 2009
Recent patents for Hedgehog pathway inhibitors for the treatment of malignancyMartin R Tremblay, Michael Nesler, Robin Weatherhead, et al.
Current Opinion in Chemical Biology|April 20, 2010
New developments in the discovery of small molecule Hedgehog pathway antagonistsMartin R Tremblay, Karen McGovern, Margaret A Read, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 23, 2005
Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiolMartin R Tremblay, Roch P Boivin, Van Luu-The, et al.
Journal of the American Chemical Society|December 11, 2003
Catalysis of the photo-Fries reaction: antibody-mediated stabilization of high energy statesTobin J Dickerson, Martin R Tremblay, Timothy Z Hoffman, et al.
Journal of Medicinal Chemistry|December 22, 2005
Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenaseDonald Poirier, Roch P Boivin, Martin R Tremblay, et al.
The Journal of Organic Chemistry|November 10, 2005
Exploring the scope of the 29G12 antibody catalyzed 1,3-dipolar cycloaddition reactionJonathan D Toker, Martin R Tremblay, Jari Yli-Kauhaluoma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinityWei Qiu, Robert L Campbell, Anne Gangloff, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Synthesis and biological evaluation of (-)-laulimalide analoguesBrian M Gallagher, Francis G Fang, Charles W Johannes, et al.
Anticancer Research|June 29, 2007
In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agentJunke Liu, Murray J Towle, Hongsheng Cheng, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Combinatorial Chemistry|July 13, 2004
Steroids and combinatorial chemistryRené Maltais, Martin R Tremblay, Liviu C Ciobanu, et al.
Expert Opinion on Therapeutic Patents|June 10, 2009
Recent patents for Hedgehog pathway inhibitors for the treatment of malignancyMartin R Tremblay, Michael Nesler, Robin Weatherhead, et al.
Current Opinion in Chemical Biology|April 20, 2010
New developments in the discovery of small molecule Hedgehog pathway antagonistsMartin R Tremblay, Karen McGovern, Margaret A Read, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 23, 2005
Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiolMartin R Tremblay, Roch P Boivin, Van Luu-The, et al.
Journal of the American Chemical Society|December 11, 2003
Catalysis of the photo-Fries reaction: antibody-mediated stabilization of high energy statesTobin J Dickerson, Martin R Tremblay, Timothy Z Hoffman, et al.
Journal of Medicinal Chemistry|December 22, 2005
Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenaseDonald Poirier, Roch P Boivin, Martin R Tremblay, et al.
The Journal of Organic Chemistry|November 10, 2005
Exploring the scope of the 29G12 antibody catalyzed 1,3-dipolar cycloaddition reactionJonathan D Toker, Martin R Tremblay, Jari Yli-Kauhaluoma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinityWei Qiu, Robert L Campbell, Anne Gangloff, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Synthesis and biological evaluation of (-)-laulimalide analoguesBrian M Gallagher, Francis G Fang, Charles W Johannes, et al.
Anticancer Research|June 29, 2007
In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agentJunke Liu, Murray J Towle, Hongsheng Cheng, et al.
Pageof 2